Community-acquired pneumonia causes great mortality and morbidity and high costs
worldwide. Empirical selection of antibiotic treatment is the cornerstone of management of …

It is difficult to determine the impact of community-acquired pneumonia (CAP) in Europe,
because precise data are scarce. Mortality attributable to CAP varies widely between …

Evidence is accumulating that vitamin D may have beneficial effects on respiratory tract,
autoimmune, neuro-degenerative, and mental diseases. The present umbrella review of …

Background People with chronic obstructive pulmonary disease (COPD) are at increased
risk of pneumococcal disease, especially pneumonia, as well as acute exacerbations with …

Community-acquired lower respiratory tract infections (LRTI) and pneumonia (CAP) are
common causes of morbidity and mortality among those aged≥ 65 years; a growing …

Background The burden of community-acquired pneumonia (CAP) caused by Streptococcus
pneumoniae (pneumococcus) among adults in Europe is poorly defined. Methods …

Community-acquired pneumonia (CAP) is an increasing problem among the elderly.
Multiple factors related to ageing, such as comorbidities, nutritional status and swallowing …

Community-acquired pneumonia (CAP) can occur at any time of life, but its incidence and
risk of death are linked to increasing age. CAP in the elderly is a major health problem …

Introduction Sarcopenia is a geriatric syndrome characterized by loss of muscle mass and
strength. The prevalence in people between 60–70 years is about 5–13% and in adults over …

The world is aging. The number of individuals aged 60 years and older is expected to
increase globally from 841 million in 2013 to more than 2 billion by 2050. 1 In the United …